Literature DB >> 11893004

Leukodystrophy and CSF purine abnormalities associated with isolated 3-methylcrotonyl-CoA carboxylase deficiency.

Raquel Dodelson de Kremer1, Alexandra Latini, Terttu Suormala, E Regula Baumgartner, Laura Laróvere, Gabriel Civallero, Norberto Guelbert, Ana Paschini-Capra, Catalina Depetris-Boldini, Carlos Quiroga Mayor.   

Abstract

We report the first case of isolated biotin resistant 3-methylcrotonyl-CoA carboxylase (MCC) deficiency in Argentina. The diagnosis was established at 14 months of age by urinary organic-acid analysis and confirmed by enzyme assay in fibroblasts. The patient suffered from severe psychomotor retardation, hypotonia, areflexia, and failure to thrive, and died unexpectedly at 3 years 4 months of life. Brain MRI at 14 months showed signals of the white matter on cerebral T2-weighted, which were indicative of confluent and multiple foci of leukodystrophy, a pattern not previously described in this entity. In addition, high levels of oxypurines were detected in cerebrospinal fluid. This might be related to energetic consequences of the enzyme deficiency in the brain. This case extends the phenotype of isolated MCC deficiency in infancy and suggests this entity should be considered to be one of the possible causes of "metabolic leukodystrophies."

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11893004     DOI: 10.1023/a:1014096112916

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  15 in total

1.  Cerebrospinal fluid hypoxanthine, xanthine and uric acid levels may reflect glutamate-mediated excitotoxicity in different neurological diseases.

Authors:  J F Stover; K Lowitzsch; O S Kempski
Journal:  Neurosci Lett       Date:  1997-11-28       Impact factor: 3.046

2.  Isolated 3-methylcrotonyl-CoA carboxylase deficiency in a 15-year-old girl.

Authors:  K Murayama; M Kimura; S Yamaguchi; T Shinka; K Kodama
Journal:  Brain Dev       Date:  1997-06       Impact factor: 1.961

3.  Cerebrospinal fluid organic acids in biotinidase deficiency.

Authors:  M Duran; E R Baumgartner; T M Suormala; L Bruinvis; L Dorland; J A Smeitink; B T Poll-The
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

4.  Isolated (biotin-resistant) 3-methylcrotonyl-CoA carboxylase deficiency: four sibs devoid of pathology.

Authors:  J Mourmans; J Bakkeren; J de Jong; R Wevers; O P van Diggelen; T Suormala; R Baumgartner; U Wendel
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

5.  [Mitochondrial 2-methylacetoacetyl-CoA thiolase deficiency in Argentina].

Authors:  R D de Kremer; C D de Boldini; R I Kelley; G E Civallero
Journal:  Medicina (B Aires)       Date:  1997       Impact factor: 0.653

6.  Glycine and L-carnitine therapy in 3-methylcrotonyl-CoA carboxylase deficiency.

Authors:  S L Rutledge; G T Berry; C A Stanley; J L van Hove; D Millington
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

Review 7.  Physiology and pathophysiology of organic acids in cerebrospinal fluid.

Authors:  G F Hoffmann; W Meier-Augenstein; S Stöckler; R Surtees; D Rating; W L Nyhan
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

8.  Congenital cytomegalovirus infection of the brain: imaging analysis and embryologic considerations.

Authors:  A J Barkovich; C E Lindan
Journal:  AJNR Am J Neuroradiol       Date:  1994-04       Impact factor: 3.825

9.  Familial hypotonia of childhood caused by isolated 3-methylcrotonyl-coenzyme A carboxylase deficiency.

Authors:  O N Elpeleg; S Havkin; V Barash; C Jakobs; B Glick; R S Shalev
Journal:  J Pediatr       Date:  1992-09       Impact factor: 4.406

10.  Isolated biotin-resistant deficiency of 3-methylcrotonyl-CoA carboxylase presenting as a clinically severe form in a newborn with fatal outcome.

Authors:  C Bannwart; B Wermuth; R Baumgartner; T Suormala; U N Weismann
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

View more
  9 in total

Review 1.  The consequences of extended newborn screening programmes: do we know who needs treatment?

Authors:  B Wilcken
Journal:  J Inherit Metab Dis       Date:  2008-02-22       Impact factor: 4.982

2.  Neurochemical evidence that the metabolites accumulating in 3-methylcrotonyl-CoA carboxylase deficiency induce oxidative damage in cerebral cortex of young rats.

Authors:  Ângela Zanatta; Alana Pimentel Moura; Anelise Miotti Tonin; Lisiane Aurélio Knebel; Mateus Grings; Vannessa Araújo Lobato; César Augusto João Ribeiro; Carlos Severo Dutra-Filho; Guilhian Leipnitz; Moacir Wajner
Journal:  Cell Mol Neurobiol       Date:  2012-09-28       Impact factor: 5.046

3.  3-Methylcrotonylglycine disrupts mitochondrial energy homeostasis and inhibits synaptic Na(+),K (+)-ATPase activity in brain of young rats.

Authors:  Alana Pimentel Moura; César Augusto João Ribeiro; Ângela Zanatta; Estela Natacha Brandt Busanello; Anelise Miotti Tonin; Moacir Wajner
Journal:  Cell Mol Neurobiol       Date:  2011-10-13       Impact factor: 5.046

4.  Intracranial Calcification Associated with 3-Methylcrotonyl-CoA Carboxylase Deficiency.

Authors:  Süleyman Şahin; Miraç Yıldırım; Ömer Bektaş; İlknur Sürücü Kara; Ahmet Cevdet Ceylan; Serap Teber
Journal:  Mol Syndromol       Date:  2021-08-26

5.  Outcomes of cases with 3-methylcrotonyl-CoA carboxylase (3-MCC) deficiency - Report from the Inborn Errors of Metabolism Information System.

Authors:  RaeLynn Forsyth; Catherine Walsh Vockley; Mathew J Edick; Cynthia A Cameron; Sally J Hiner; Susan A Berry; Jerry Vockley; Georgianne L Arnold
Journal:  Mol Genet Metab       Date:  2016-02-15       Impact factor: 4.797

6.  3-methylcrotonyl-CoA carboxylase deficiency: clinical, biochemical, enzymatic and molecular studies in 88 individuals.

Authors:  Sarah C Grünert; Martin Stucki; Raphael J Morscher; Terttu Suormala; Celine Bürer; Patricie Burda; Ernst Christensen; Can Ficicioglu; Jürgen Herwig; Stefan Kölker; Dorothea Möslinger; Elisabetta Pasquini; René Santer; K Otfried Schwab; Bridget Wilcken; Brian Fowler; Wyatt W Yue; Matthias R Baumgartner
Journal:  Orphanet J Rare Dis       Date:  2012-05-29       Impact factor: 4.123

7.  Consanguinity and rare mutations outside of MCCC genes underlie nonspecific phenotypes of MCCD.

Authors:  Peter J Shepard; Bruce A Barshop; Matthias R Baumgartner; John-Bjarne Hansen; Kristen Jepsen; Erin N Smith; Kelly A Frazer
Journal:  Genet Med       Date:  2014-11-06       Impact factor: 8.822

8.  Brain magnetic resonance imaging and proton MR spectroscopic findings after metabolic crisis in 3-methylcrotonylglycinuria.

Authors:  Ghazi Adlan Alshumrani; Zoltan Patay
Journal:  Ann Saudi Med       Date:  2015 Jan-Feb       Impact factor: 1.526

9.  Expanded Newborn Screening for Inborn Errors of Metabolism by Tandem Mass Spectrometry in Suzhou, China: Disease Spectrum, Prevalence, Genetic Characteristics in a Chinese Population.

Authors:  Ting Wang; Jun Ma; Qin Zhang; Ang Gao; Qi Wang; Hong Li; Jingjing Xiang; Benjing Wang
Journal:  Front Genet       Date:  2019-10-29       Impact factor: 4.599

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.